Sivik Global Healthcare LLC Boosts Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Sivik Global Healthcare LLC grew its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 35.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 135,588 shares of the exchange traded fund’s stock after acquiring an additional 35,588 shares during the quarter. SPDR S&P Biotech ETF accounts for about 5.1% of Sivik Global Healthcare LLC’s investment portfolio, making the stock its largest holding. Sivik Global Healthcare LLC owned about 0.18% of SPDR S&P Biotech ETF worth $12,107,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of XBI. Migdal Insurance & Financial Holdings Ltd. acquired a new position in SPDR S&P Biotech ETF in the 3rd quarter worth $102,900,000. Healthcare of Ontario Pension Plan Trust Fund boosted its position in shares of SPDR S&P Biotech ETF by 103.3% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,771,000 shares of the exchange traded fund’s stock worth $129,318,000 after buying an additional 900,000 shares during the period. Employees Retirement System of Texas bought a new position in shares of SPDR S&P Biotech ETF during the third quarter worth about $27,456,000. MBB Public Markets I LLC raised its position in SPDR S&P Biotech ETF by 67.0% in the 3rd quarter. MBB Public Markets I LLC now owns 514,411 shares of the exchange traded fund’s stock valued at $37,562,000 after buying an additional 206,337 shares during the last quarter. Finally, abrdn plc bought a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $14,436,000.

SPDR S&P Biotech ETF Price Performance

NYSEARCA:XBI traded down $0.90 during trading hours on Tuesday, reaching $84.62. 7,413,647 shares of the stock were exchanged, compared to its average volume of 11,658,005. The stock has a market cap of $6.57 billion, a PE ratio of 11.47 and a beta of 1.08. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52. The firm has a 50 day moving average of $92.54 and a 200 day moving average of $84.94.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.